A clinical research consortium sponsored by NIAID and JDRF
A research trial of Aralast in new-onset type 1 diabetes
Contact Us
RETAIN is no longer enrolling participants.
For information about the EXTEND study, another type 1 diabetes clinical trial being conducted by the Immune Tolerance Network, please visit extendstudy.org.
Study Locations
Connecticut
Closed
Yale University School of Medicine
Yale Center for Clinical Investigation
2 Church Street South
Suite 401
,
New Haven, CT
06519
Principal Investigator:
Kevan Herold, MD
Contact for more information:
Georgia
Closed
Atlanta Diabetes Associates
1800 Howell Mill Road
Suite 450
,
Atlanta, GA
30318
Principal Investigator:
Bruce Bode, MD
Contact for more information:
Closed
Emory University
Children's Healthcare of Atlanta
2015 Uppergate Drive, NE ,
Atlanta, GA
30322
Principal Investigator:
Eric Felner, MD
Contact for more information:
Iowa
Closed
The University of Iowa Children's Hospital
200 Hawkins Drive ,
Iowa City, IA
52242
Principal Investigator:
Eva Tsalikian, MD
Contact for more information:
Massachusetts
Closed
Joslin Diabetes Center
One Joslin Place ,
Boston, MA
02215
Principal Investigator:
Gordon Weir, MD
Contact for more information:
Missouri
Closed
Children’s Mercy Hospital and Clinics
2401 Gilliam Rd. ,
Kansas City, MO
64108
Principal Investigator:
Wayne Moore, MD
Contact for more information:
New York
Closed
Columbia University
Naomi Berrie Diabetes Center
1150 St. Nicholas Ave.
2nd Floor
,
New York, NY
10032
Principal Investigator:
Robin Goland, MD
Contact for more information:
Ohio
Closed
Nationwide Children’s Hospital
545 South 18th St. ,
Columbus, OH
43205
Principal Investigator:
Robert Hoffman, MD
Contact for more information:
Pennsylvania
Closed
Children’s Hospital of Philadelphia (CHOP)
3401 Civic Center Blvd. ,
Philadelphia, PA
43205
Principal Investigator:
Steven Willi, MD
Contact for more information:
Washington
Closed
Pacific Northwest Research Institute (PNRI)
720 Broadway ,
Seattle, WA
98122
Principal Investigator:
William Hagopian, MD
Contact for more information:
